// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Synergistic cytotoxicity and genotoxicity of polycyclic aromatic hydrocarbons and blue light in retinal pigment epithelium cells

Corinne Zinflou - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Everolimus

Photo-conversion of A2E by high-energy visible light

Marie-Christine Lambert - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

DMSO

Biochemical analysis of mutations in transmembrane domain one of ABCA4 responsible for Stargardt Macular Degeneration

Fabian Garces - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

N/A

N/A

Treatment of noninfectious intermediate uveitis with dexamethasone (Ozurdex) intravitreal implant.

Christopher Welsh - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

N/A

Dexamethasone

Practice Patterns of Canadian Ophthalmological Society members in Cataract Surgery - Survey 2017

Dara Onasanya - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

N/A

N/A

Quality improvement: where is gonioscopy?

Beatrice Des Marchais - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Assessing the effects of indomethacin and dexamethasone on wound healing using a 3D bioartificial tissue of human Tenon’s capsule fibroblasts

Jim Denstedt - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Dexamethasone

Effect of Tobacco Smoking on Outcomes of Trabeculectomy

Nadia Rios Acosta - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

N/A

N/A

Mesenchymal stromal cells promote vascular regeneration and modulate inflammation in a mouse model of ischemic retinopathy

Baraa Noueihed - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

Interleukin-10

Enhancing Retinal Ganglion Cell Production from Human Pluripotent Stem Cell-Derived 3D Retinal Cultures

Xiangmei Zhang - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Enhancement of mitotic activity in the chick retina following optic nerve section and growth factor treatment

Vivian Choh - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Identification of protein components of the rod outer segment plasma membrane by label-free protein correlation profiling

Nikolai P Skiba - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Smartphone and tablet usage among individuals with vision impairment: Are mainstream devices replacing traditional visual aids?

Natalie Martiniello - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

Characterization of retinal structure in ATF6-associated achromatopsia

Rebecca Mastey - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

N/A

N/A

Cone photoreceptors and optical signals to defocus following emmetropization to lenses in chicks

Mengyuan Ke - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Ranibizumab treatment for nAMD in clinical practice: outcomes from the LUMINOUSâ„¢ study

Sanjay Sharma - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Ranibizumab

Clinical outcomes and safety profile of scleral fixated AKREOS AO60 lens

Nour Nofal - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Optical coherence tomography angiography of dissociated optic nerve fiber layer appearance after internal limiting membrane peeling for full thickness macular hole

Nathan Schuck - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Prevalence of Meibomian Gland Dysfunction in Sjogren’s Syndrome Patients

Sruthi Srinivasan - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Lid laxity and Concurrent Signs of Ocular Surface Disease

Tracy Doll - The Association for Research in Vision and Ophthalmology (ARVO) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved